Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2023 / May / Better Breast Cancer Care for All
Oncology Digital and computational pathology Oncology Insights

Better Breast Cancer Care for All

How digital pathology has the potential to improve outcomes in regions that traditionally lack access to high quality diagnoses

By Sadaf Sarfraz, Muhammad Mustafa 05/08/2023 Future 2 min read

Share

Breast cancer is one of the most common types of cancer among women all over the world – but not all women receive the same level of care. Both digital pathology and translational medicine hold great potential to improve breast cancer outcomes for all patients – particularly those in low- and middle-income countries.

Breast cancer is a major health concern globally. High-income countries have access to advanced technologies and resources for breast cancer diagnosis and treatment. Low and middle-income countries lack the level of access to high-quality diagnoses, which can lead to poor outcomes for patients. Digital pathology and translational medicine have the potential to address some of these challenges, but their use in low and medium countries is not without limitations and challenges.

Sadaf Sarfraz

For example, in countries where access to medical professionals is limited, digital pathology can allow samples to be analyzed remotely. Patients can receive diagnosis remarks or a second opinion even if there is no pathologist available. This is specifically important for breast cancer cases, where early detection is critical for successful treatment. Leveraging digital technologies and scientific discoveries will achieve better treatment plans and ultimate cures regardless of geographic location or access to resources.

Similarly, translational medicine improves the prognosis of breast cancer in low and medium-income countries. It can do so by bringing the latest discoveries in cancer research in collaboration with international partners to identify new biomarkers or mutations that can be targeted with drugs thus implementing more effective and personalized breast cancer treatment.

Muhammad Mustafa

The limitation to the implementation of digital pathology and translational medicine in low and medium-income countries is the lack of resources and infrastructure. The cost of implementing digital pathology can be prohibitive for many health facilitators. The lack of electricity and reliable internet connection facilities pose a problem in some areas. Language and cultural barriers make it difficult to access people in many locations.

In conclusion, digital pathology and translational medicine have the potential to revolutionize the way we approach breast cancer diagnosis and treatment in low and medium-income countries by improving the access to accurate diagnosis and the latest treatments. We can help women to overcome this devastating disease and live healthy lives with continued investment and research. We can work toward a future where breast cancer patients in low and medium-income countries have the access to the best and most effective treatments improving the quality of life for every female equally across high to low-income countries.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Sadaf Sarfraz

M.Phil. Molecular pathology and genomics, Forman Christian College (A Chartered University).

More Articles by Sadaf Sarfraz

Muhammad Mustafa

Assistant Professor, Forman Christian College (A Chartered University).

More Articles by Muhammad Mustafa

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.